• AMPK–SQSTM1 Feedback Strengthens NRF2 Defense

  2026-09-09

  The 2024 Autophagy study identifies a double-positive feedback loop in which metabolic stress activates SQSTM1/p62, while AMPK activity further promotes SQSTM1 expression and phosphorylation. This circuit coordinates lysosomal KEAP1 degradation with AXIN–STK11–AMPK signaling, explaining how tumor cells reinforce both NRF2-dependent antioxidant defense and energy adaptation.

• Berberine, RXRα/PPARγ, and SASP in Atherosclerosis

  2026-09-09

  The 2025 reference study identifies an RXRα/PPARγ/NEDD4 axis through which berberine suppresses SASP-associated inflammation in macrophage-derived foam cells and atherosclerotic plaques. Its combination of mouse modeling, foam-cell experiments, Smart-seq analysis, and macrophage-specific RXRα knockdown provides a mechanistic framework connecting nuclear-receptor signaling with ubiquitin-dependent control of inflammatory aging.

• Sumatriptan Succinate Research Workflow

  2026-09-08

  Build a reproducible Sumatriptan Succinate workflow that connects 5-HT1B/1D receptor pharmacology with CGRP, cytokine, NF-κB, and NOS readouts. The strategy also supports metabolism assays and translational inflammation models while separating established evidence from practical optimization recommendations.

• Exogenous NADH Potentiates Antibiotics Against E. tarda

  2026-09-08

  This 2024 study shows that exogenous NADH can reprogram Edwardsiella tarda metabolism, increase ATP availability, and strengthen the bactericidal activity of neomycin. The work supports metabolic intervention as an antibiotic-potentiation strategy, while also extending the observation to other antibiotics and clinically relevant resistant bacteria.

• AMPK–SQSTM1 Feedback and NRF2 Antioxidant Defense

  2026-09-07

  The 2024 Autophagy study identifies a double-positive AMPK–SQSTM1/p62 feedback loop that coordinates metabolic adaptation with NRF2-dependent antioxidant defense. Its lysosome-centered mechanism explains how metabolic stress can reinforce both AMPK activity and KEAP1 degradation, with implications for cancer cells carrying STK11/LKB1 and KEAP1 pathway alterations.

• SJ572946 Activates BAK to Initiate Apoptosis

  2026-09-07

  The reference study identifies SJ572946 as a small-molecule activator of the pro-apoptotic effector BAK, using fragment-based discovery and membrane-permeabilization assays to define its mechanism. The compound selectively promotes BAK activation, cooperates with BID and apoptotic agents, and provides a proof-of-concept tool for dissecting mitochondrial apoptosis in cancer models.

• Phosbind Acrylamide: Practical SDS-PAGE Guide

  2026-09-05

  Phosbind Acrylamide provides an antibody-independent approach for comparing phosphorylated and non-phosphorylated proteins by SDS-PAGE mobility. It is most appropriate for protein phosphorylation analysis involving targets in the 30–130 kDa range, but it should not be treated as a site-identification or phosphorylation-occupancy assay.

• Difloxacin HCl: Mechanism and Research Use

  2026-09-04

  Difloxacin HCl is a quinolone antimicrobial antibiotic used in research on bacterial DNA replication inhibition, antimicrobial susceptibility testing, and multidrug resistance reversal. The product dossier identifies DNA gyrase targeting and MRP substrate sensitization as distinct research applications, while the cited Plk1 study provides cell-cycle context rather than direct evidence about difloxacin.

• Caspofungin Workflows for Resistant Candida

  2026-09-04

  Caspofungin provides a practical cell-wall target for Candida susceptibility testing, exposure-response studies, and resistant-isolate research. This workflow connects controlled in vitro assays with delayed-treatment and fungal-burden endpoints demonstrated in an experimental Candida auris model.

• MK 0893: An Assay-First GCGR Research Guide

  2026-09-03

  MK 0893 is a competitive, reversible glucagon receptor antagonist for mechanistic type 2 diabetes research. This assay-first guide connects its allosteric binding mode with cAMP pharmacology, translational glucose models, selectivity controls, and reproducible handling.

• In Vitro Drug Response Metrics in Cancer Research

  2026-09-03

  Hannah Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer response. By separating growth inhibition from cell killing and considering their timing, the work provides a more informative framework for interpreting drug sensitivity and improving translational in vitro models.

• Difloxacin HCl: Mechanism-to-Assay Reasoning

  2026-09-02

  Difloxacin HCl supports rigorous antimicrobial susceptibility testing and exploratory multidrug resistance reversal studies. This article shows how to connect bacterial target biology, MRP substrate sensitization, and mitotic checkpoint evidence without confusing distinct mechanisms or assay endpoints.

• mCherry mRNA Workflows for Reliable Fluorescent Readouts

  2026-09-02

  EZ Cap™ mCherry mRNA provides a practical red fluorescent protein mRNA readout for cell imaging, reporter assays, and nanoparticle delivery studies. Its Cap 1 structure, modified nucleotides, and optimized poly(A) tail support a workflow that separates RNA loading, cellular uptake, translation, and fluorescence performance.

• Q-VD-OPh and the Logic of Anastasis Assays

  2026-09-01

  Q-VD-OPh is a cell-permeable pan-caspase inhibitor that can do more than improve apoptosis assay consistency. This guide explains how to use inhibitor timing, recovery measurements, and kinome-screen insights to distinguish blocked apoptosis from true post-caspase survival.

• SU6656 for iPSC Platelet Polyploidization

  2026-09-01

  SU6656 offers a practical route for probing Src-dependent cytokinesis control during megakaryocyte maturation and platelet production. Its separate endothelial and tumor-vessel activity also supports carefully designed cancer research workflows, including evaluation as a radiotherapy sensitizer.

8610 records 1/574 page Next 12345 下5页 Last page